23 May 2024Open access
Plasma CD24 level as a promising prognostic biomarker of hepatocellular carcinomaPublisher siteEgyptian Liver Journal, Hepatocellular Carcinoma Treatment and Prognosis
Active, last published 2026
In acute myeloid leukemia research
Shereen Abdel Monem
Ibrahim
Scholar“Research focused on Acute Myeloid Leukemia Research and adjacent fields.”
Ain Shams University
Egypt
Claim Your ProfileEgypt2
H-index
8
Citations
Shereen has not officially claimed their profile. If you are Shereen, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
hereen Abdel Monem Ibrahim is a researcher working on Acute Myeloid Leukemia Research. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Shereen's work has been cited 8 times across 1 active year. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Acute Myeloid Leukemia Research×2
04 · Where I am
Affiliations
Affiliation on published researchAin Shams University, EgyptDrawn from the institution listed on this researcher’s published work.
05 · Selected work
Recent publications
1 workExpert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Shereen?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you